Expression of SOCS genes in normal and leukemic human leukocytes stimulated by prolactin, growth hormone and cytokines

Journal of Neuroimmunology

Volumn 109, Issue 1, 2000, Pages 34-39

  Dogusan, Z ^a   Hooghe Peters, E L ^a   Berus, D ^a   Velkeniers, B ^a   Hooghe, R ^a,b  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^b FLEMISH INSTITUTE FOR TECHNOLOGICAL RESEARCH VITO   (Belgium)

Author keywords

Bone marrow; Granulocyte; JAK; Receptor; Signal transduction; STAT

Indexed keywords

CYTOKINE; CYTOKINE RECEPTOR; GROWTH HORMONE; INTERLEUKIN 1BETA; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE; PROLACTIN; RNA; STAT PROTEIN;

ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; GENE EXPRESSION; GRANULOCYTE; HORMONAL REGULATION; HUMAN; HUMAN CELL; LEUKEMIA CELL; LEUKOCYTE; LYMPHOMA CELL; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

CELL LINE; CYTOKINES; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; GROWTH HORMONE; HUMANS; LEUKEMIA; PROLACTIN; PROTEINS; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

EID: 0034284144     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(00)00300-3     Document Type: Article

References (36)

1. Bouchard B., Ormandy C.J., Di Santo J.P., Kelly P.A. Immune system development and function in prolactin receptor-deficient mice. J. Immunol. 163:1999;576-582.
2. Carter-Su C., Smit L.S. Signaling via JAK tyrosine kinases: growth hormone receptor as a model system. Recent Prog. Horm. Res. 53:1998;61-83.
3. Cohney S.J., Sanden D., Cacalano N.A., Yoshimura A., Mui A., Migone T.S., Johnston J.A. SOCS-3 is tyrosine phosphorylated in response to interleukin-2 and suppresses STAT5 phosphorylation and lymphocyte proliferation. Mol. Cell Biol. 19:1999;4980-4988.
4. Dickensheets H.L., Venkataraman C., Schindler U., Donnelly R.P. Interferons inhibit activation of STAT6 by interleukin 4 in human monocytes by inducing SOCS-1 gene expression. Proc. Natl. Acad. Sci. USA. 96:1999;10800-10805.
5. Dorshkind K., Horseman N. The roles of prolactin (PRL), growth hormone (GH), insulin-like growth factor-I (IGF-I), and thyroid hormones in lymphocyte development and function: insights from genetic models of hormone and hormone receptor deficiency. Endocrine Rev. 21:2000;292-313.
6. Elly C., Witte S., Zhang Z., Rosnet O., Lipkowitz S., Altman A., Liu Y.C. Tyrosine phosphorylation and complex formation of Cbl-b upon T cell receptor stimulation. Oncogene. 18:1999;1147-1156.
7. Fu Y.K., Arkins S., Fuh G., Cunningham B.C., Wells J.A., Fong S., Cronin M.J., Dantzer R., Kelley K.W. Growth hormone augments superoxide anion secretion of human neutrophils by binding to the prolactin receptor. J. Clin. Invest. 89:1992;451-457.
8. Hansen J.A., Lindberg K., Hilton D.J., Nielsen J.H., Billestrup N. Mechanism of inhibition of growth hormone receptor signaling by suppressor of cytokine signaling proteins. Mol. Endocrinol. 13:1999;1832-1843.
9. Harmer S.L., DeFranco A.L. The src homology domain 2-containing inositol phosphatase SHIP forms a ternary complex with Shc and Grb2 in antigen receptor-stimulated B lymphocytes. J. Biol. Chem. 274:1999;12183-12191.
10. Helman D., Sandowski Y., Cohen Y., Matsumoto A., Yoshimura A., Merchav S., Gertler A. Cytokine-inducible SH2 protein (CIS3) and JAK2 binding protein (JAB) abolish prolactin receptor-mediated STAT5 signaling. FEBS Lett. 441:1998;287-291.
11. Hibi M., Hirano T. Signal transduction through cytokine receptors. Int. Rev. Immunol. 17:1998;75-102.
12. Hilton D.J. Negative regulators of cytokine signal transduction. Cell. Mol. Life Sci. 55:1999;1568-1577.
13. Hooghe-Peters, E.L., Dogusan, Z., Hooghe, R., 2000. In vitro effects of prolactin on the lympho-hemopoietic system. In: Horseman, N. (Ed.), Prolactin. Kluwer Academic Publishers, Dordrecht (in press).
14. Horseman N.D., Yu-Lee L.-Y. Transcriptional regulation by the helix bundle peptide hormones: growth hormone, prolactin, and hematopoietic cytokines. Endocrine Rev. 15:1994;627-649.
15. Horseman N.D., Zhao W., Montecino-Rodriguez E., Tanaka M., Nakashima K., Engle S.J., Smith F., Markoff E., Dorshkind K. Defective mammopoiesis, but normal hematopoiesis, in mice with a targeted disruption of the prolactin gene. EMBO J. 16:1997;6926-6935.
16. Ingham R.J., Okada H., Dang-Lawson M., Dinglasan J., van Der Geer P., Kurosaki T., Gold M.R. Tyrosine phosphorylation of shc in response to B cell antigen receptor engagement depends on the SHIP inositol phosphatase. J. Immunol. 163:1999;5891-5895.
17. Ito S., Ansari P., Sakatsume M., Dickensheets H., Vazquez N., Donnelly R.P., Larner A.C., Finbloom D.S. Interleukin-10 inhibits expression of both interferon alpha- and interferon gamma-induced genes by suppressing tyrosine phosphorylation of STAT1. Blood. 93:1999;1456-1463.
18. Kooijman R., Berus D., Malur A., Delhase M., Hooghe-Peters E.L. Human neutrophils express GH-N gene transcripts and the pituitary transcription factor Pit-1b. Endocrinology. 138:1997;4481-4484.
19. Kooijman R., Hooghe-Peters E.L., Hooghe R. Prolactin, growth hormone, and insulin-like growth factor-I in the immune system. Adv. Immunol. 63:1996;377-454.
20. Liu B., Liao J., Rao X., Kushner S.A., Chung C.D., Chang D.D., Shuai K. Inhibition of Stat1-mediated gene activation by PIAS1. Proc. Natl. Acad. Sci. USA. 95:1998;10626-10631.
21. Marine J.C., McKay C., Wang D., Topham D.J., Parganas E., Nakajima H., Pendeville H., Yasukawa H., Sasaki A., Yoshimura A., Ihle J.N. SOCS3 is essential in the regulation of fetal liver erythropoiesis. Cell. 98:1999;617-627.
22. Matera L., Bellone G., Lebrun J.J., Kelly P.A., Hooghe-Peters E.L., Di Celle P.F., Foa R., Contarini M., Avanzi G., Asnaghi V. Role of prolactin in the in vitro development of interleukin-2-driven anti-tumoural lymphokine-activated killer cells. Immunology. 89:1996;619-626.
23. Matsumoto A., Masuhara M., Mitsui K., Yokouchi M., Ohtsubo M., Misawa H., Miyajima A., Yoshimura A. CIS, a cytokine inducible SH2 protein, is a target of the JAK-STAT5 pathway and modulates STAT5 activation. Blood. 89:1997;3148-3154.
24. Matuoka K., Miki H., Takahashi K., Takenawa T. A novel ligand for an SH3 domain of the adaptor protein Nck bears an SH2 domain and nuclear signaling motifs. Biochem. Biophys. Res. Commun. 239:1997;488-492.
25. Mayr S., Welte T., Windegger M., Lechner J., May P., Heinrich P.C., Horn F., Doppler W. Selective coupling of STAT factors to the mouse prolactin receptor. Eur. J. Biochem. 258:1998;784-793.
26. Newburger P.E., Subrahmanyam Y.V., Weissman S.M. Global analysis of neutrophil gene expression. Curr. Opin. Hematol. 7:2000;16-20.
27. Nosaka T., Kawashima T., Misawa K., Ikuta K., Mui A.L., Kitamura T. STAT5 as a molecular regulator of proliferation, differentiation and apoptosis in hematopoietic cells. EMBO J. 18:1999;4754-4765.
28. Paris N., Rentier-Delrue F., Defontaine A., Goffin V., Lebrun J.J., Mercier L., Martial J.A. Bacterial production and purification of recombinant human prolactin. Biotechnol. Appl. Biochem. 12:1990;436-449.
29. Pezet A., Favre H., Kelly P.A., Edery M. Inhibition and restoration of prolactin signal transduction by suppressors of cytokine signaling. J. Biol. Chem. 274:1999;24497-24502.
30. Sakamoto S., Nie J., Taniguchi T. Phorbol ester induction of IFN-gamma receptors leads to enhanced DR alpha gene expression. J. Immunol. 162:1999;4381-4384.
31. Song M.M., Shuai K. The suppressor of cytokine signaling (SOCS) 1 and SOCS3 but not SOCS2 proteins inhibit interferon-mediated antiviral and antiproliferative activities. J. Biol. Chem. 273:1998;35056-35062.
32. van Leeuwen J.E., Samelson L.E. T cell antigen-receptor signal transduction. Curr. Opin. Immunol. 11:1999;242-248.
33. Verdier F., Rabionet R., Gouilleux F., Beisenherz-Huss C., Varlet P., Muller O., Mayeux P., Lacombe C., Gisselbrecht S., Chretien S. A sequence of the CIS gene promoter interacts preferentially with two associated STAT 5A dimers: a distinct biochemical difference between STAT5A and STAT5B. Mol. Cell. Biol. 18:1998;5852-5860.
34. Yoshimura A. The CIS/JAB family: novel negative regulators of JAK signaling pathways. Leukemia. 12:1998;1851-1857.
35. Yoshimura A., Ohkubo T., Kiguchi T., Jenkins N.A., Gilbert D.J., Copeland N.G., Hara T., Miyajima A. A novel cytokine-inducible gene C.I.S. encodes an SH2-containing protein that binds to tyrosine-phosphorylated interleukin 3 and erythropoietin receptors. EMBO J. 14:1995;2816-2826.
36. Yu-Lee L.-Y., Luo G., Moutoussamy S., Finidori J. Prolactin and growth hormone signal transduction in lymphohaemopoietic cells. Cell. Mol. Life Sci. 54:1998;1067-1075.